Peggy Farness

809 total citations
11 papers, 679 citations indexed

About

Peggy Farness is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Peggy Farness has authored 11 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Peggy Farness's work include Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and vaccines and immunoinformatics approaches (2 papers). Peggy Farness is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and vaccines and immunoinformatics approaches (2 papers). Peggy Farness collaborates with scholars based in United States, Italy and Russia. Peggy Farness's co-authors include Antonella Vitiello, Glenn Ishioka, H M Grey, Francis V. Chisari, Ruben Rose, Julie Furze, Rebecca LaFond, John Sidney, Alessandro Sette and Robert W. Chesnut and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Peggy Farness

11 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peggy Farness United States	9	438	278	175	110	101	11	679
You Suk Suh South Korea	12	468 1.1×	329 1.2×	194 1.1×	111 1.0×	161 1.6×	19	762
Danushka K. Wijesundara Australia	16	344 0.8×	252 0.9×	195 1.1×	184 1.7×	53 0.5×	39	741
Marie-Louise Michel France	8	361 0.8×	287 1.0×	245 1.4×	131 1.2×	58 0.6×	12	678
Petra Riedl Germany	15	378 0.9×	250 0.9×	231 1.3×	101 0.9×	33 0.3×	32	617
Rebecca LaFond United States	7	308 0.7×	183 0.7×	124 0.7×	67 0.6×	30 0.3×	9	511
Marie J. Estcourt Australia	13	617 1.4×	227 0.8×	228 1.3×	93 0.8×	197 2.0×	25	927
Auda A. Eltahla Australia	15	247 0.6×	199 0.7×	239 1.4×	223 2.0×	60 0.6×	25	752
Andreas R. Kammer Switzerland	12	335 0.8×	346 1.2×	163 0.9×	94 0.9×	35 0.3×	13	793
Clare Thompson United States	9	680 1.6×	153 0.6×	157 0.9×	98 0.9×	119 1.2×	12	836
Susan Smyk‐Pearson United States	8	733 1.7×	336 1.2×	93 0.5×	132 1.2×	64 0.6×	8	994

Countries citing papers authored by Peggy Farness

Since Specialization

Citations

This map shows the geographic impact of Peggy Farness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Farness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Farness more than expected).

Fields of papers citing papers by Peggy Farness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Farness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Farness. The network helps show where Peggy Farness may publish in the future.

Co-authorship network of co-authors of Peggy Farness

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Farness. A scholar is included among the top collaborators of Peggy Farness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Farness. Peggy Farness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Espinosa, Diego A., Jason Mendy, Darly J. Manayani, et al.. (2017). Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge. EBioMedicine. 27. 61–70. 42 indexed citations

Alexander, Jeff, Jason Mendy, Lo Vang, et al.. (2013). Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C. PLoS ONE. 8(12). e82380–e82380. 18 indexed citations

Alexander, Jeff, Simone Visosky Ward, Jason Mendy, et al.. (2012). Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin. PLoS ONE. 7(2). e31177–e31177. 44 indexed citations

Alexander, Jeff, Marc Gurwith, Jason Mendy, et al.. (2012). Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. Retrovirology. 9(S2). 1 indexed citations

Millard, Frederick, Mara Gerloni, Denise Darrah, Peggy Farness, & Maurizio Zanetti. (2004). Phase I study of transgenic B lymphocyte immunization (TLI) against telomerase in androgen-independent prostate cancer (PC). Journal of Clinical Oncology. 22(14_suppl). 2519–2519. 6 indexed citations

Montagna, Daniela, Rita Maccario, Franco Locatelli, et al.. (2001). Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood. 98(12). 3359–3366. 47 indexed citations

Granziero, Luisa, Stanisław Krajewski, Peggy Farness, et al.. (1999). Adoptive immunotherapy prevents prostate cancer in a transgenic animal model. European Journal of Immunology. 29(4). 1127–1138. 52 indexed citations

Vitiello, Antonella, Alessandro Sette, Peggy Farness, et al.. (1997). Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance. European Journal of Immunology. 27(3). 671–678. 58 indexed citations

Vitiello, Antonella, Yuan Li, Robert W. Chesnut, et al.. (1996). Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. The Journal of Immunology. 157(12). 5555–5562. 109 indexed citations

10.

Vitiello, Antonella, Glenn Ishioka, H M Grey, et al.. (1995). Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.. Journal of Clinical Investigation. 95(1). 341–349. 288 indexed citations

11.

Sette, Alessandro, Antonella Vitiello, Peggy Farness, et al.. (1991). Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. The Journal of Immunology. 147(11). 3893–3900. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact